GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) » Definitions » ROE %

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) ROE % : 0.00% (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is PT Diagnos Laboratorium Utama Tbk ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. PT Diagnos Laboratorium Utama Tbk's annualized net income for the quarter that ended in . 20 was Rp Mil. PT Diagnos Laboratorium Utama Tbk's average Total Stockholders Equity over the quarter that ended in . 20 was Rp Mil. Therefore, PT Diagnos Laboratorium Utama Tbk's annualized ROE % for the quarter that ended in . 20 was %.

The historical rank and industry rank for PT Diagnos Laboratorium Utama Tbk's ROE % or its related term are showing as below:

ISX:DGNS's ROE % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -6.025
* Ranked among companies with meaningful ROE % only.

PT Diagnos Laboratorium Utama Tbk ROE % Historical Data

The historical data trend for PT Diagnos Laboratorium Utama Tbk's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Diagnos Laboratorium Utama Tbk ROE % Chart

PT Diagnos Laboratorium Utama Tbk Annual Data
Trend
ROE %

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data
ROE %

Competitive Comparison of PT Diagnos Laboratorium Utama Tbk's ROE %

For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Diagnos Laboratorium Utama Tbk's ROE % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's ROE % distribution charts can be found below:

* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's ROE % falls into.



PT Diagnos Laboratorium Utama Tbk ROE % Calculation

PT Diagnos Laboratorium Utama Tbk's annualized ROE % for the fiscal year that ended in . 20 is calculated as

ROE %=Net Income (A: . 20 )/( (Total Stockholders Equity (A: . 20 )+Total Stockholders Equity (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

PT Diagnos Laboratorium Utama Tbk's annualized ROE % for the quarter that ended in . 20 is calculated as

ROE %=Net Income (Q: . 20 )/( (Total Stockholders Equity (Q: . 20 )+Total Stockholders Equity (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (. 20) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


PT Diagnos Laboratorium Utama Tbk  (ISX:DGNS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=( / )*( / )*( / )
=Net Margin %*Asset Turnover*Equity Multiplier
= %**
=ROA %*Equity Multiplier
= %*
= %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= ( / ) * ( / ) * ( / ) * ( / ) * ( / )
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= * * % * *
= %

Note: The net income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


PT Diagnos Laboratorium Utama Tbk ROE % Related Terms

Thank you for viewing the detailed overview of PT Diagnos Laboratorium Utama Tbk's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Diagnos Laboratorium Utama Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Teuku Cik Ditiro 1 No. 11 A, B, C, Gedung Graha Anam, 2nd Floor, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350
PT Diagnos Laboratorium Utama Tbk provides laboratory services that include health support service activities that are managed by both the government and the private sector, such as health laboratories. The business products and services include Clinical Pathology Laboratory, Anatomy Pathology Laboratory, Genomic Laboratory, Homecare Health Services, and Corporate Health Service.

PT Diagnos Laboratorium Utama Tbk Headlines

From GuruFocus

Cvent CEO & Founder to Present at Water Tower Research Fireside Chat

By Business Wire Business Wire 11-12-2021

Cvent and Dragoneer to Present at Water Tower Research Fireside Chat

By Business Wire Business Wire 11-29-2021

Cvent Announces New Independent Board Members for Post-Merger Company

By Business Wire Business Wire 12-01-2021